Evidence map›Paper›PMID 33430076›Full record

ArticleAntibiotics (Basel, Switzerland)2021

Enhanced Antimicrobial and Antibiofilm Effect of New Colistin-Loaded Human Albumin Nanoparticles.

Sara Scutera, Monica Argenziano, Rosaria Sparti, Federica Bessone, Gabriele Bianco, Chiara Bastiancich, Carlotta Castagnoli, Maurizio Stella, Tiziana Musso, Roberta Cavalli

Abstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. The use of combination therapy for the improvement of colistin activity against bacterial biofilm.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2024
    Review
  11. Article
  12. Co-regulation of biofilm formation and antimicrobial resistance in Acinetobacter baumannii: from mechanisms to therapeutic strategies.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2023
    Review
  13. Review
  14. Article
  15. Review
  16. Tobramycin Nanoantibiotics and Their Advantages: A Minireview.International journal of molecular sciences · 2022
    Review
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sara ScuteraDepartment of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.ORCID 0000-0002-7431-0875
Monica ArgenzianoDepartment of Drug Science and Technology, University of Turin, 10124 Turin, Italy.ORCID 0000-0002-8485-7460
Rosaria SpartiDepartment of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.
Federica BessoneDepartment of Drug Science and Technology, University of Turin, 10124 Turin, Italy.
Gabriele BiancoMicrobiology and Virology Unit, University Hospital Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Chiara BastiancichDepartment of Drug Science and Technology, University of Turin, 10124 Turin, Italy.ORCID 0000-0003-2758-5654
Carlotta CastagnoliSkin Bank, Department of General and Specialized Surgery, University Hospital Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Maurizio StellaBurn Center, CTO Hospital, Città della Salute e della Scienza di Torino, 10126 Turin, Italy.
Tiziana MussoDepartment of Public Health and Pediatric Sciences, University of Turin, 10126 Turin, Italy.
Roberta CavalliDepartment of Drug Science and Technology, University of Turin, 10124 Turin, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Multidrug-resistant (MDR) Gram-negative bacteria (GNB), such as

Indexed as

biofilmcolistinhuman albuminMDR strainsnanoparticles

Identifiers

PMID33430076
PMCPMC7827731

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.